Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

J.m. De Laat

Clinical trials sponsored by J.m. De Laat, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

PRIME study: precision radiotherapy using MR-linac for pancreatic neuroendocrine tumours in MEN1 patients Results expected Jul 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1

PRIME study: precision radiotherapy using MR-linac for pancreatic neuroendocrine tumours in MEN1 patients

Ongoing

Patients with the Multiple Endocrine Neoplasia type 1 (MEN1) syndrome are genetically predisposed for developping multiple pancreatic neuro-endocrine tumours (pNET). The management of small (pNET) in both MEN1 and sporadic cases, pose a major clinical challenge. At present, pancr…

Sponsor: J.M. de Laat

Last updated Sep 09, 2026 17:00 UTC